Profiel
Samuel Agus is currently the Chief Medical Officer at Biophytis, Inc. He previously held the same position at Biophytis SA from 2018 to 2021 and at Hansa Biopharma AB from 2017 to 2018.
Agus holds a doctorate degree from Tel-Aviv University and The Hebrew University of Jerusalem.
Actieve functies van Samuel Agus
| Bedrijven | Functie | Begin |
|---|---|---|
Biophytis, Inc.
Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes | Hoofd Techniek/Wetenschap/O&O | 01-07-2018 |
Eerdere bekende functies van Samuel Agus
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOPHYTIS S.A. | Hoofd Techniek/Wetenschap/O&O | 07-07-2021 |
| HANSA BIOPHARMA AB | Hoofd Techniek/Wetenschap/O&O | 01-06-2018 |
Opleiding van Samuel Agus
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Biophytis SA
Biophytis SA Pharmaceuticals: OtherHealth Technology Develops and markets dietary supplements and ingredients for functional food based on tropical plants | Health Technology |
Biophytis, Inc.
Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes | Health Technology |
















